Carl Kohrt, vice president and general manager of Eastman Kodak'sHealth Sciences division, has found himself in privileged companyat the Rochester, NY, film giant. Kohrt joined chief executiveGeorge Fisher as one of three executives named to a new
Carl Kohrt, vice president and general manager of Eastman Kodak'sHealth Sciences division, has found himself in privileged companyat the Rochester, NY, film giant. Kohrt joined chief executiveGeorge Fisher as one of three executives named to a new chiefoperating office designed be the nucleus of Kodak's senior managementteam.
In announcing the moves last week, Fisher said the new teamwould handle the day-to-day operations of Kodak's global business.All the business, manufacturing, R&D and geographic regionsthat previously reported to other executives will report to thenew office. Kohrt will remain head of the Health Sciences unit.
Fisher will add COO to his titles of chairman, president andCEO, while Kohrt adds executive vice president and assistant COOto his resume. Joining Fisher and Kohrt on the team is DanielCarp, vice president and general manager of Kodak's European,African and Middle Eastern region.
Kodak said the moves were being made to strengthen the nextgeneration of Kodak's management team, making Kohrt and Carp automaticfront-runners in the event Fisher leaves the company.
Fisher was named to lead Kodak in 1993 and has dramaticallyincreased the company's focus on digital imaging (SCAN 4/12/94).He has said he intends to remain with the company at least throughhis current contract, which runs until 1998.
Kohrt, a 24-year Kodak veteran who has headed Health Sciencesfor four years, has led the division to increased worldwide marketshare despite an era of dramatic change and consolidation, Fishersaid.
"Carl Kohrt has defined Kodak's leadership in one of themost challenging markets in the world today, health care,"Fisher said.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.